MANNKIND CORP

MNKD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2010 FY2009 FY2008 FY2007 FY2006 FY2005 FY2004 FY2003
Revenue $93.0K
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development
SG&A Expense $40.3M $53.4M
Operating Income $-152.5M $-209.8M
Operating Margin -163,976.3%
Interest Expense $17.4M $4.8M
Pretax Income $-170.6M $-220.1M
Income Tax Expense
Net Income $-170.6M $-220.1M $-303.0M $-293.2M $-230.5M $-114.3M $-76.0M $-65.9M
Net Margin -183,397.8%
EPS (Basic) $-1.50 $-2.07
EPS (Diluted) $-1.50 $-2.07
Shares Outstanding (Basic) 127.8M
Shares Outstanding (Diluted) 127.8M
Dividends Per Share
← Newer Page 3 of 5 Older →